Loading viewer...
earnings
Format: PDF earnings
Organon's fourth quarter and full year 2023 earnings presentation includes financial performance results, 2024 guidance estimates, and updates on product franchises and commercialization strategy. The presentation covers non-GAAP financial measures including Adjusted EBITDA, Adjusted gross margin, and Adjusted diluted EPS, with reconciliations to GAAP results. Forward-looking statements address the company's product development plans, business development strategy, and market position in contraception and fertility products.
investor_presentation
25 Pages
earnings
13 Pages
CSRA
Brunswick Q2 2016 Earnings Conference Call
earningsearnings
44 Pages
Brunswick Corporation
Rand Capital Q2 2024 Earnings Results
earningsearnings
17 Pages
Rand Capital Corporation